Account

Industry resources and insights

Sort by year
  • All time
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018 and older
Articles
10.09.2024
Strategic approaches to achieving HTA approval for...

Achieving HTA approval for orphan drugs requires strategic planning, early engagement, strong eviden...

Read more
Insider Insights
05.09.2024
NICE’s 1000th Appraisal: Iptacopan for Paroxysma...

The recent appraisal by the National Institute for Health and Care Excellence (NICE) for Iptacopan, ...

Read more
News
03.09.2024
World Orphan Drug Congress Europe 2024

We're thrilled to announce our participation at World Orphan Drug Congress Europe 2024 in Barcelona ...

Read more
News
29.08.2024
ISPOR Europe 2024

We're delighted to announce our participation at ISPOR Europe 2024 in Barcelona this November. We'll...

Read more
Articles
28.08.2024
How to integrate Market Access strategy with evide...

Introduction What is the secret to a successful drug launch? One crucial factor is establishing a cr...

Read more
Insider Insights
28.08.2024
NICE rejects first drug proven to slow Alzheimerâ€...

Despite positive outcomes in treating Alzheimer's disease, NICE cites small benefits and high costs ...

Read more
Load more
Browse by topic
  • Biosimilars
  • Devices & Diagnostics
  • Digital Health
  • Early Access
  • Early Payer Dialogue
  • Emerging & Developing Markets
  • Funding
  • Gene Therapy & ATMPs
  • HTA
  • International Reference Pricing
  • Launch
  • Managed Entry Agreements
  • Medicine manufacturing
  • NICE
  • Oncology
  • Orphan Drugs
  • PMA Trends
  • Pricing
  • Rare Diseases
  • Real World Evidence
  • Team Remap
  • Tendering & Procurement
  • Training
Content type
  • All
  • Articles
  • Case Studies
  • Insider Insights
  • News
  • Publications
  • Webinar
Subscribe
Hidden
Consent
This field is for validation purposes and should be left unchanged.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch